57526-82-6 Usage
Description
(S)-1-[p-(benzyloxy)phenoxy]-3-(isopropylamino)propan-2-ol is a complex chemical compound characterized by its chiral (S) configuration. It features a propanol group with an isopropylamino substituent and a phenol group with a benzyloxy substituent. (S)-1-[p-(benzyloxy)phenoxy]-3-(isopropylamino)propan-2-ol is predominantly utilized in the fields of organic synthesis and medicinal chemistry research, where it may hold potential for drug development and serves as a reference compound in analytical chemistry. Further investigation and research are necessary to explore its specific properties and possible applications.
Uses
Used in Organic Synthesis:
(S)-1-[p-(benzyloxy)phenoxy]-3-(isopropylamino)propan-2-ol is used as a key intermediate in the synthesis of various organic compounds. Its unique structure and reactivity make it a valuable building block for creating novel molecules with potential applications in different industries.
Used in Medicinal Chemistry Research:
In the field of medicinal chemistry, (S)-1-[p-(benzyloxy)phenoxy]-3-(isopropylamino)propan-2-ol is used as a starting material or a structural component in the development of new pharmaceuticals. Its complex structure and chirality may contribute to the discovery of innovative drugs with improved efficacy and selectivity.
Used in Drug Development:
(S)-1-[p-(benzyloxy)phenoxy]-3-(isopropylamino)propan-2-ol holds potential for direct application in drug development. Its specific properties, such as the presence of the propanol and phenol groups, may enable the design of new therapeutic agents targeting various diseases and conditions.
Used in Analytical Chemistry as a Reference Compound:
Due to its defined structure and chirality, (S)-1-[p-(benzyloxy)phenoxy]-3-(isopropylamino)propan-2-ol is used as a reference compound in analytical chemistry. It aids in the calibration of analytical instruments, validation of methodologies, and the development of new techniques for the analysis and characterization of chiral compounds.
Used in Pharmaceutical Industry:
(S)-1-[p-(benzyloxy)phenoxy]-3-(isopropylamino)propan-2-ol is used as a precursor or building block in the pharmaceutical industry for the synthesis of new drugs. Its unique structural features may lead to the development of innovative therapeutic agents with improved pharmacological properties.
Check Digit Verification of cas no
The CAS Registry Mumber 57526-82-6 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 5,7,5,2 and 6 respectively; the second part has 2 digits, 8 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 57526-82:
(7*5)+(6*7)+(5*5)+(4*2)+(3*6)+(2*8)+(1*2)=146
146 % 10 = 6
So 57526-82-6 is a valid CAS Registry Number.
InChI:InChI=1/C19H25NO3/c1-15(2)20-12-17(21)14-23-19-10-8-18(9-11-19)22-13-16-6-4-3-5-7-16/h3-11,15,17,20-21H,12-14H2,1-2H3/t17-/m0/s1
57526-82-6Relevant articles and documents
Substituted (10H-phenothiazin-10-L)-propyl-1-piperazines
-
, (2008/06/13)
Substituted (10H-phenothiazin-10-yl)propyl-1-piperazines of the formula STR1 wherein R1, R2, R3, A, X, m, n and s are as hereinafter set forth, are described. The compounds of formula I, which contain a piperazine moiety combined by an ether linkage to different phenolic moieties, are useful as orally active long lasting antipsychotic agents.
Process for inverting the configuration in optically active compounds
-
, (2008/06/13)
The invention relates to a process for inverting the configuration in optically active compounds of the formula STR1 in which Ar1 represents a monocyclic or polycyclic, carbocyclic or heterocyclic radical that has at least one ring of aromatic character and is bonded to the oxygen atom by way of a ring carbon atom, preferably of the ring of aromatic character, and R1 represents an optionally substituted aliphatic, cycloaliphatic or araliphatic hydrocarbon radical, or the salts thereof, characterised in that an optically active compound of the formula STR2 having a R(+) or S(-) configuration, in which R2 represents a monocyclic or polycyclic, carbocyclic or heterocyclic radical, or an optionally substituted aliphatic, cycloaliphatic or araliphatic hydrocarbon radical, is converted, by treating with a strong oxygen-containing inorganic or organic acid or halides thererof, into an optically active compound of the formula STR3 in which X? represents the anion of a strong, oxygen-containing inorganic or organic acid or of a halogen atom and the resulting compound of the formula III is hydrolysed, optionally by way of the corresponding free base as intermediate, to form a compound of the formula I of a configuration opposite to that of the starting material used and, if desired, a free compound of the formula I is converted into a salt or a resulting salt is converted into the free compound.
Phenoxy substituted glycosides
-
, (2008/06/13)
1-Phenoxy-2-hydroxy-3-amino-propanes of the formula I EQU1 wherein R1 is a sugar residue and R2 is isopropyl, tert.-butyl or α-methyl-phenethyl optionally substituted in the phenyl part, and the salts thereof are useful as positively inotropic agents, especially in the treatment of insufficiency of the cardiac muscle.
